Zobrazeno 1 - 10
of 16
pro vyhledávání: '"E. H. Ortiz"'
Autor:
Daniel F. Hayes, Kaitlin Einhaus, Gary H. Lyman, Mark R. Somerfield, Thomas K. Oliver, Alok A. Khorana, Kari Bohlke, Robert S. Miller, Neelima Denduluri, George P. Browman, E. H. Ortiz, Supriya G. Mohile
Publikováno v:
Journal of Clinical Oncology. 34:3213-3220
Since the beginning of its guidelines program in 1993, ASCO has continually sought ways to produce a greater number of guidelines while maintaining its commitment to using the rigorous development methods that minimize the biases that threaten the va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a370cc984652aa80a1709cf9017fcb11
https://doi.org/10.1200/jco.2016.68.3524
https://doi.org/10.1200/jco.2016.68.3524
Autor:
Cristian Micheri, Luis Fein, Martin Eduardo Richardet, Ezequiel Klimovsky, E. H. Ortiz, Florencia Visintini Jaime, Mirta Susana Varela, Lucas Cordeiro, Andrea Federico, Nestor Lago, Susana Kahl, Ruben Dario Kowalyszyn, Gustavo Cortese, Jorge Horacio Cassini, J. J. Zarba
Publikováno v:
Journal of Clinical Oncology. 37:3113-3113
3113 Background: Peg-Neutropine, GEMA BIOTECH SAU biosimilar Peg-Filgrastim, is the first Peg-Filgrastim approved in LATAM for prevention of febrile neutropenia in patients treated with myelosuppressive chemotherapy. Methods: Study population: women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a748accc545c018b3725e76b1aca8335
https://doi.org/10.1200/jco.2019.37.15_suppl.3113
https://doi.org/10.1200/jco.2019.37.15_suppl.3113
Autor:
Maria Ester Dominguez, Ariel Osvaldo Zwenger, Jose Pablo Leone, Julian Iturbe, A Romero, Julieta Leone, E. H. Ortiz, Hebe Margot Fasce, M Machiavelli, Mario Langui, Luis A. Romero Acuña, J E Perez, Carlos Teodoro Vallejo, Bernardo Amadeo Leone
Publikováno v:
Breast Cancer Research and Treatment. 143:313-323
Neoadjuvant chemotherapy (NAC) allows direct evaluation of the tumor's sensitivity to therapy, eradication of micrometastatic disease and the possibility of performing breast conserving surgery. The aim of this study was to describe long-term results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b79001ad2a0847f4f222258dd3d257f
https://doi.org/10.1007/s10549-013-2806-5
https://doi.org/10.1007/s10549-013-2806-5
Publikováno v:
Journal of Neuroscience Research. 86:2663-2673
We have used a model of iron deficiency in the rat to analyze the effects of a disruption in iron availability on oligodendroglial cell (OLGc) maturation and myelinogenesis and to explore the possible beneficial influence of an intracranial injection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8cf22519eeefb28f4c92de0ca3a916
https://doi.org/10.1002/jnr.21709
https://doi.org/10.1002/jnr.21709
Autor:
Bernardo Amadeo Leone, J. M. Romero Acuna, M A Cuevas, L. Romero Acuna, M Machiavelli, Vito Lorusso, S. Amato, M. R. Barbieri, A Romero, M. J. Langhi, E. H. Ortiz, R. Rodriguez, Manuel Domínguez, M. A. Salvadori, J E Perez, M. DeLena, Carlos Teodoro Vallejo, C. L. Sabatini, J. A. Lacava
Publikováno v:
American Journal of Clinical Oncology. 21:94-98
A phase II trial was performed to evaluate the efficacy and toxicity of a double modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) and L-leucovorin (L-LV) in patients with advanced recurrent (inoperable) or metastatic colorectal carcinoma (AC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475be8466be84efe598707480683ebd0
https://doi.org/10.1097/00000421-199802000-00022
https://doi.org/10.1097/00000421-199802000-00022
Autor:
R. Rodriguez, M A Cuevas, C. L. Sabatini, J. A. Lacava, Bernardo Amadeo Leone, L A Acuña, M Machiavelli, Maria Ester Dominguez, M. A. Salvadori, E. H. Ortiz, Carlos Teodoro Vallejo, J M Acuña, M. J. Langhi, M R Barbieri, S. Amato, J E Perez, A Romero
Publikováno v:
Journal of Clinical Oncology. 14:2993-2999
PURPOSE To evaluate the efficacy and toxicity of the combination of ifosfamide (IFX) and vinorelbine (VNB) as first-line chemotherapy in metastatic breast cancer (MBC). PATIENTS AND METHODS Between August 1993 and August 1995, 45 patients with untrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e749071436909c7628ae93ced0b978e
https://doi.org/10.1200/jco.1996.14.11.2993
https://doi.org/10.1200/jco.1996.14.11.2993
Autor:
E. H. Ortiz, K. Demoliner, Alicia Rodriguez-Gabin, Q. Si, Jorge N. Larocca, Guillermina Almazan
Publikováno v:
Journal of neuroscience research. 88(3)
Rab31, a protein that we cloned from an oligodendrocyte cDNA library, is required for transport of mannose 6-phosphate receptors (MPRs) from the trans-Golgi network (TGN) to endosomes and for Golgi/TGN organization. Here we extend the knowledge of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f3666d6612e0065a0a23b7328b5674
https://pubmed.ncbi.nlm.nih.gov/19795375
https://pubmed.ncbi.nlm.nih.gov/19795375
Autor:
J E Perez, E. H. Ortiz, Carlos Teodoro Vallejo, Fabrina Bologna, A Romero, Bernardo Amadeo Leone, J. A. Lacava, Salum G, M Machiavelli, Manuel Domínguez
Publikováno v:
American journal of clinical oncology. 27(2)
The purpose of this report is to evaluate the efficacy and toxicity (Tx) of a double modulation of 5-fluorouracil (5-FU) by trimetrexate (TMTX) and leucovorin (LV) in patients with advanced recurrent (inoperable) or metastatic colorectal cancer (ACC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386d4bbf411b35b018bfe9f37eaa5ede
https://pubmed.ncbi.nlm.nih.gov/15057154
https://pubmed.ncbi.nlm.nih.gov/15057154
Autor:
M. A. Barbieri, Carlos Teodoro Vallejo, J. M. Romero Acuna, Hebe Margot Fasce, E. H. Ortiz, L. Romero Acuna, S. Grasso, M. J. Langhi, Bernardo Amadeo Leone, J E Perez, R. Rodriguez, M Machiavelli, S. Amato, A Romero, J. A. Lacava
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(1)
PURPOSE: To evaluate the efficacy and toxicity of a combination of vinorelbine (VNB) and paclitaxel (PTX) as first-line chemotherapy in metastatic breast carcinoma (MBC). PATIENTS AND METHODS: Between August 1995 and August 1997, 49 patients with unt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::667f4b7de000999ca29921736a393355
https://pubmed.ncbi.nlm.nih.gov/10458220
https://pubmed.ncbi.nlm.nih.gov/10458220
Autor:
M. J. Langhi, Carlos Teodoro Vallejo, J. A. Lacava, J. M. Romero Acuna, M. R. Barbieri, J E Perez, R. Rodriguez, N. Marrone, Manuel Domínguez, Bernardo Amadeo Leone, A Romero, L. Romero Acuna, M Machiavelli, E. H. Ortiz, S. Amato
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 18(8)
A phase II trial was carried out by the Grupo Oncologico Cooperativo del Sur (G.O.C.S.) to assess the efficacy and toxicity of a biochemical modulation of 5-fluorouracil (5-FU) by i.v. pretreatment with interferon (IFN)-alpha2b in patients with advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642e96033a786ab1b11ce0eb5b0c4eb7
https://pubmed.ncbi.nlm.nih.gov/9726437
https://pubmed.ncbi.nlm.nih.gov/9726437